Table 2.
Clinical variables | Histologic subtype |
P value (Fisher's exact)* | ||||||
---|---|---|---|---|---|---|---|---|
ARMS (n = 33) | ERMS (n = 53) | SRMS-ScRMS (n = 13) | ||||||
Gender | 0.541 | |||||||
Male | 19 | 58% | 25 | 47% | 8 | 61% | ||
Female | 14 | 42% | 28 | 53% | 5 | 39% | ||
Age (years) | Mean | 23 | 8.7 | 29 | <0.001 (ANOVA) | |||
Median | 23 | 6 | 28 | <0.001 Kruskal-Wallis | ||||
Max. | 57 | 38 | 72 | |||||
Min. | 0.08 | 0.3 | 0.7 | |||||
Age group | <0.001 | |||||||
Adult | 22 | 67% | 7 | 13% | 8 | 61% | ||
Pediatric | 11 | 33% | 46 | 87% | 5 | 39% | ||
Tumor site | <0.001 | |||||||
PM | 28 | 85% | 33 | 62% | 3 | 23% | ||
S | 4 | 12% | 11 | 21% | 10 | 77% | ||
O | 1 | 3% | 9 | 17% | 0 | 0% | ||
Tumor size | Mean | 4 | 4 | 5 | 0.344 (ANOVA) | |||
Median | 4 | 4 | 5 | 0.517 Kruskal-Wallis | ||||
Max. | 9 | 12 | 10 | |||||
Min. | 1 | 1.3 | 0.8 | |||||
Regional lymph node | <0.001 | |||||||
Positive | 24 | 72% | 14 | 27% | 2 | 17% | ||
Negative | 9 | 28% | 38 | 73% | 10 | 83% | ||
Initial metastasis | 0.078 | |||||||
Positive | 10 | 30% | 6 | 11% | 3 | 23% | ||
Negative | 23 | 70% | 47 | 89% | 10 | 77% | ||
Stage | 0.001 | |||||||
1 | 4 | 12% | 16 | 30% | 9 | 69% | ||
2 | 2 | 6% | 8 | 15% | 0 | 0% | ||
3 | 17 | 52% | 23 | 44% | 1 | 8% | ||
4 | 10 | 30% | 6 | 11% | 3 | 23% | ||
Recurrence | 0.001 | |||||||
LR | 6 | 18% | 3 | 6% | 2 | 18% | ||
DR, (LR & DR) | 8 | 24% | 1 | 2% | 2 | 18% | ||
NR | 19 | 58% | 49 | 92% | 7 | 64% | ||
Vital status | 0.05 | |||||||
Alive | 20 | 61% | 43 | 81% | 6 | 54% | ||
Deceased | 13 | 39% | 10 | 19% | 5 | 46% | ||
Follow-up duration (months) | Mean | 63 | 106 | 35 | <0.001 (ANOVA) | |||
Median | 32 | 104 | 29 | <0.001 Kruskal-Wallis | ||||
Max. | 232 | 232 | 94 | |||||
Min. | 4 | 7 | 4 |
PM – Parameningeal, S – Non parameningeal non orbital, O – Orbital, LR – Local recurrence, DR – Distant recurrence, NR – No recurrence
P values calculated with Fisher's exact if not otherwise specified